Bone marrow mesenchymal stromal cells (MSCs) suppress immune cell responses and have beneficial effects in various inflammatory-related immune disorders. A therapeutic modality for systemic inflammation and its consequences is not available yet. Thus, this work investigates the therapeutic effects of MSCs in injury models induced by lipopolysaccharide (LPS) or burn. Gene expression was analyzed in MSCs when exposed to inflammatory serum from injured animals and it showed remarkable alterations compared to normal culture. In addition, injured animals were transplanted intramuscularly with MSCs. Forty-eight hours after cell transplantation, kidney, lung, and liver were analyzed for infiltration of inflammatory cells and TUNEL-expressing cells. Results showed that MSCs attenuate injury by reducing the infiltration of inflammatory cells in various target organs and by reducing cell death. These data suggest that MSCs emerge as key regulators of immune/inflammatory responses in vivo and as attractive candidates for cell-based treatments for systemic inflammatory-based disorders.
INTRODUCTION
been studied in several clinical settings of immune/inflammatory disease, which includes graft-versus-host disease (GVHD) (28) , ischemic heart disease (17), is-Trauma, sepsis, and burn related syndromes are the fifth leading cause of death for all age groups, ranking chemic kidney injury (27), type 2 diabetes mellitus (14), ischemic tissues (4), and Crohn' disease (15, 30, 31) . Our just behind heart diseases, cancer, stroke, and chronic diseases (20) . All these disorders have been identified to group has described the immunomodulatory functions of MSCs and their secreted molecules in immune-related have a severe inflammatory response to injury (10, 20) . Over one third of all in-hospital patients, including more animal models of acute liver failure and enteropathy (35, 41) . These results to date indicate that the secreted than 50% of all intensive care unit (ICU) patients, and greater than 80% of surgical patients show a certain de-bioactive molecules of MSCs provide a regenerative microenvironment for a variety of injured adult tissues, gree of systemic inflammation. Although systemic inflammation is a normal response to injury, it may facili-which limits the area of damage and allows a self-regulated regenerative response. Because the complexity of tate the development of serious complications added to the underlying injury (19, 29) . Even with improved treat-the mechanism of fine control between immunity and tolerance, which are involved not only in preventing in-ments of trauma and critical care patients, and the reduction in mortality in those patients that develop multior-fection or inflammation but also in limiting collateral immune-mediated tissue damage, underlines the critical gan dysfunction syndrome (MODS), there are still >50% of patients with MODS who die (3, 8, 39) . nature of immunomodulatory activity, MSCs could represent a viable innate regulatory unit by this dynamic There have been many clinical attempts to control the inflammatory response using specific anticytokine or response.
Although all the immune modulators, secreted mole-antimediator therapies (9, 12) . Recently, MSCs have 824 YAGI ET AL. cules, and bioactive functions are yet to be described, 0.4 mg/kg body weight) and analgesia (buprenorphine 1 mg/kg body weight) following a modified procedure as the data available clearly support the concept that the paracrine function of MSCs has a therapeutic effect dur-previously described (38) . Rats were anesthetized, shaved, and received a 30% TBSA scald burn (100°C ing sepsis, a condition characterized by a whole-body inflammatory state (32) .
water; water contact 10 s to the back). After thermal injury, rats were immediately resuscitated by IP injec-Here we demonstrate the therapeutic potential of MSCs in two different animal models of injury induced tion of Ringer's lactate (50 ml/kg body weight). by LPS and 30% burn, both of which are known to initi-LPS Induction ate an increase in the proinflammatory state with multiple organ injury (21, 22, 24) . We show the positive im-Lipopolysaccharide (LPS; extracted from Escherichia coli 0111: B4) was purchased from Sigma (St. pact of the transplantation of MSCs by histological alterations in multiple vital organs and with the upregu-Louis, MO). To induce endotoxemia in animal 10 mg/ kg of LPS was injected intraperitoneum. lation of anti-inflammatory and antiapoptotic gene expression in MSCs exposed to inflammatory conditions.
MSC Transplantation MATERIALS AND METHODS
MSCs (2 × 10 6 ) were suspended in 500 µl of PBS Animals with 2.5 mg/ml of rat type 1 collagen (Trevigen, Gaithersburg, MD) and administered to the left thigh muscle Male Sprague-Dawley rats weighing 270-320 g of the animals immediately after the induction of burn (Charles River Laboratories, Boston, MA) were used for or LPS. burn and sepsis induction. The animals were cared for in accordance with the guidelines set forth by the Com-Serum Collection From Burn-and LPS-Induced mittee on Laboratory Resources, National Institutes of Animals for Cell Culture Study Health, and Subcommittee on Research Animal Care Rats' carotid arteries were cannulated 24 h before and Laboratory Animal Resources of Massachusetts treating under general anesthesia (IP injections of keta-General Hospital. All animals had free access to food mine and xylazine at 110 and 0.4 mg/kg body weight) and water, both before and after the operation.
prior to the transplantation of MSC. Serum of injured MSC Culture animals was collected at 12 and 24 h after the induction; blood was drawn from carotid artery and the serum was Human MSCs were kindly provided by the Tulane stored at −80°C until used for cell culture studies. Center for Gene Therapy (New Orleans, LA). MSCs were cultured and characterized for surface marker ex-Histological Studies pression and adipocytic and osteogenic differentiation Kidney, lung, and liver from each experimental group capacity as previously reported (1). Cells were used for (control burn rats, control LPS rats, MSC-treated burn experiments during passages 3-7. To quantify the gene rats, and MSC-treated LPS rats) were collected at 24 h expression of the activated MSCs, 0.5 × 10 6 MSCs were after the induction of burn or LPS. Formalin-fixed, parcultured 24 h in 10% bovine serum using six-well plates affin-embedded liver samples were sectioned at 4 µm and after washing by phosphate-buffered saline (PBS) thickness and stained with hematoxylin and eosin cells were exposed to 10% serum from burn (burn-(H&E). For terminal deoxynucleotidyl transferase-mediderived serum) or LPS (LPS-derived serum) induced ated nick-end labeling (TUNEL) staining of the liver, rats as described below. After culturing in the serum for we used the DeadEnd Fluorometric TUNEL System 24 h, medium was collected and stored at −80°C until (Promega, Madison, WI) according to the vendor's inanalyzed by PCR.
structions. Quantification of cell numbers in stained tis-Quantitative Real-Time RT-PCR sue sections was performed in 10 random 40× images per animal using the public software ImageJ (http://rsb. Quantitative real-time RT-PCR was performed in info.nih.gov/ij/). Quantitative evaluation of the kidney Strategene MXPro 3005p (La Jolla, CA) using human injury was performed based on histological parameters: NF-κB signaling pathway PCR arrays from SABiotubular necrosis, interstitial edema, loss of brush border, sciences (Frederick, MD) following the manufacturer's and casts formation. The scoring system used was 0, recommendations.
absent; 1, present; and 2, marked, as described pre-Burn Induction viously (40) . Quantitative evaluation of the lung injury was performed via a grading system by inflammatory Each rat received a 30% total body surface area (TBSA) full-thickness scald burn under general anesthe-cell infiltration, interstitial edema, intra-alveolar edema, and alveolar integrity as described previously (11). In-sia (IP injections of ketamine and xylazine at 110 and flammatory cell infiltration in liver samples was quanti-settings (17,28,34), only a few have shown their capacities in inflammatory-derived injuries (32) . Based on our fied by counting mononuclear inflammatory cells in portal and periportal areas. TUNEL-positive cells were previous studies (36, 42) and gene expression profiling, we hypothesized that MSCs can attenuate organ injury quantified using appropriate criteria for a specific threshold of staining intensity as well as corresponding via secretion of anti-inflammatory and antiapoptotic molecules when they are activated by an inflammatory sizes of the nuclei. Blind analysis of the histological samples was performed by two independent observers. environment. To evaluate the systemic effect of transplanted MSCs in multiple organs, we sampled three vital Statistical Analysis organs at 24 h after the transplantation, namely, lung, Data represent the mean ± SD of each experiment. kidney and liver, which are known to present alterations Statistical significance was determined by a Student's tafter exposure to LPS (6) . test analysis, in which each value was compared with First, we administered MSCs in endotoxemic animals the control values performed with Prism (GraphPad using LPS injection (Fig. 2) . Kidney injury after treat-Software, La Jolla, CA). ment was quantified by serum BUN level ( Fig. 2A) , inflammatory scoring (Fig. 2C , E-G), and counting of ap-RESULTS optotic cell numbers via TUNEL-positive cells (Fig. 2D ,
MSCs Alter Gene Expression in Response
H). BUN levels were significantly reduced by MSC to Inflammatory Serum Stimulation treatment (35.5 ± 7.64 mg/dl) compared to control animals (50.2 ± 7.82 mg/dl; p = 0.0158) ( Fig. 2A) . Histo-To determine if MSCs can be activated and alter dylogical analysis demonstrated a significant reduction of namically their gene expression, we first studied the rekidney tissue injury (p < 0.0001) ( Fig. 2D, E) with less ciprocal response of MSCs to inflammatory signals apoptotic cells (p = 0.0009) ( Fig. 2D, H) in MSC-treated found in the serum of injured animals. To this end, we animals compared to controls. Lung injury was also performed quantitative RT-PCR for four genes in MSCs quantified by inflammatory scoring and counting of apoafter 24 h of stimulation with LPS-derived serum or ptotic cell numbers. Histological analysis demonstrated burn-derived serum, namely, interleukin (IL)-10, V-akt a significant reduction of lung tissue injury (p = 0.0002) murine thymoma viral oncogene homolog 1 (Akt1), (Fig. 2C, F) with less apoptotic cells (p = 0.0001) ( field of view) compared to control animals (80 ± 30.25/ its production by MSCs is controversial (33, 36) . Gene field of view; p = 0.0009) ( Fig. 2C, G) . These histologiexpression analysis showed approximately threefold cal appearances are consistent with the decreased serohigher gene expression of IL-10 in MSCs, which were logical levels of AST in animals treated with MSCs exposed to either inflammatory serum, compared to nor- (Fig. 2B) . These results indicate that transplantation of mal culture control (Fig. 1A) . Akt1 is also known as an MSCs could effectively reduce inflammatory infiltration important regulator of cell survival (5) and indeed MSCs and cell death in several organs after LPS induced-injury overexpressing Akt1 have been successfully adminisin rats. tered in ischemic heart disease (17). Moreover, MSCs showed upregulation of Akt1, when exposed to the in-Transplantation of MSCs Improves Serology flammatory conditions (Fig. 1B) . Two other genes, and Organ Injury in Burned Rats which also play important roles in cell survival and are Burn injury is also known to cause organ injury subrelate to IL-10 signaling pathway (23, 26) , were similarly sequent to a state of general inflammation (21) . To deupregulated in MSCs when exposed to inflammatory termine if MSCs have a therapeutic effect in organ inconditions cause by LPS. However, MAP3K1, was jury caused by burn injury, we administered MSCs to downregulated in MSCs when exposed to burn-derived burn-induced rats and analyzed their serological and hisserum (Fig. 1C, D) . These findings clearly demonstrate tological appearances (Fig. 3) . that MSCs can alter their gene expression profile, asso-Kidney injury after treatment was quantified by seciated with inflammation and cell survival, once they are rum BUN level (Fig. 3A) , inflammatory scoring ( Fig.  stimulated with inflammatory signals. 3C, E-G), and counting of apoptotic cell numbers via Intramuscular Transplantation of MSCs Improves TUNEL-positive cells (Fig. 3D, H-J) . The BUN level Serology and Organ Injury in Endotoxemic Rats was significantly reduced by MSC treatment (26 ± 7.07 mg/dl) compared to control animals (63.8 ± 16.9 mg/dl; Although many reports have described the therapeutic potential of MSC transplantation in different clinical p = 0.0043) (Fig. 3A) . Histological analysis demon- strated the significant reduction of kidney tissue injury DISCUSSION (p < 0.0001) ( Fig. 3C , E) with less apoptotic cells (p < 0.0001) (Fig. 3D, H) 
in MSC-treated animals compared
This study demonstrates that transplantation of MSCs can attenuate the effects of systemic inflammation and to controls. These results of reduced kidney injury were more apparent than those observed in LPS-treated rats.
organ injury in two different animal models of injury. This therapeutic effect was observed in all three vital Lung injury was also quantified by inflammatory scoring and counting of apoptotic cell numbers. Histological organs in LPS endotoxemic animals and particularly in kidney and lung in burn-induced animals, demonstrating analysis demonstrated a significant reduction of lung tissue injury (p < 0.0001) (Fig. 3C, F) with less apoptotic the anti-inflammatory and antiapoptotic effects of MSCs. These results suggested that the effect of MSCs cells (p = 0.0018) (Fig. 3D, I) in MSC-treated animals compared to controls, which was similar to the result in on each disease was slightly different depending on the injury induced, which is supported by previous reports LPS endotoxemic animals. Histological analysis of liver sections showed significantly less inflammatory cell infil-that have described different mechanisms of injury caused by LPS or burn injury (13, 25) . Although the tration (13.17 ± 6.74/field of view) compared to control animals (38.83 ± 14.26/field of view; p = 0.0026) ( Fig. mechanism of injury is different in each disease, the MSCs provided a significant therapeutic benefit at the 3C, G). However, these histological results did not lead to a significant decrease in serological levels of AST in ani-same critical time point. This outcome observed in these two different animal models demonstrating a fine adjust-mals treated with MSCs (Fig. 3B) . These results confirm that MSC could effectively reduce inflammatory infiltra-ment of MSCs to the surrounding environment in vivo is significant to investigate a clinically feasible modality tion and cell death in multiple organs after burn injury; however, the targeted organ was slightly different in burn for the treatment of injuries that result in severe systemic inflammation or even MODS. animals compared to LPS endotoxemic animals.
The result of gene expression analysis supports the selves (33, 36) . Based on our current results, it is possible that the differences in IL-10 expression seen in these hypothesis that MSCs act as dynamic cells (42) that can be activated by an inflammatory environment and alter reports is due to differences in the local cellular environment (i.e., level of inflammation) surrounding the MSCs. their characteristics (genome and secretome) while providing immunomodulation. These results would facili-It has been reported that genetically engineered MSCs expressing Akt could induce an antiapoptotic ef-tate the characterization of the dynamics, duration, and trajectory of the systemic inflammatory response and fect to cells via subsequent signal transduction in an ischemic heart disease model (16) . Our results support the would permit the identification of possible targets for therapies and possible predictive biomarkers.
notion that the activation of Akt1 signaling pathway of transplanted MSCs can provide an antiapoptotic effect IL-10 is one of the key cytokines with anti-inflammatory capacities, and it has been demonstrated that MSCs in a clinical setting of systemic inflammation. In addition, kidney injury in severe burn, which was seen in can affect the secretion of IL-10 in macrophages or dendritic cells (2,32). However, it is still controversial if our experiment, has been reported to be controlled by MAPK signaling pathway (25) . Taken together, these MSCs can secrete therapeutic levels of IL-10 by them- alterations of gene expression would provide a new velopment of improved therapeutic and predictive clinical outcome strategies caused by different injuries. strategy to define an important therapeutic target of MSC treatment.
Moreover, these results would be of considerable importance for the development of novel and much needed Although MSCs are known to have immunosuppressive properties affecting T cells (7) or dendritic cells approaches to predict and treat injury effectively before critical complications develop. (31) via secretion of numerous molecules, which include various cytokines and chemokines (37) , there are few
